The 14th World Clinical Biomarkers & Companion Diagnostics Summit returns this September as the leading forum for diagnostic stakeholders. This year, enjoy an extended four-day agenda packed with new content and enhanced networking opportunities, uniting drug developers, diagnostics providers, payers and coalitions to share insights and accelerate biomarker-driven clinical trials.

Whether you're working with small molecules, large biologics, or other modalities, this year’s agenda has been carefully curated to strengthen your early disease biomarker discovery, clinical biomarker strategy, reimbursement clarity, and drug-diagnostics commercialization. Join over 500 fellow senior leaders across Biomarkers, Translational Medicine, Precision Medicine, Companion Diagnostics, Commercialization, Regulation, and more to drive the future of precision medicine and improve patient outcomes.